Hepatitis C and tumors: immune checkpoint inhibitors safe and effective?

被引：0
|
作者：
Simon, Annika
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 02期
关键词：
D O I：
10.1055/a-2181-4090
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Wirkstoffe aus der Gruppe der Immun-Checkpoint-Inhibitoren (ICI) haben in den letzten Jahren die Krebstherapie revolutioniert und konnten auch fur Patient*innen mit soliden Tumorerkrankungen und komorbider chronischer Hepatitis-C-Infektion eine neue Therapieoption darstellen. Yibirin et al. wollten daher mehr uber den virologischen Einfluss der ICI und ihre Sicherheit erfahren, und haben eine prospektive Beobachtungsstudie zum Thema durchgefuhrt.
引用
收藏
页码：156 / 158
页数：2
相关论文
共 50 条
  • [21] Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?
    Zhu, Lin
    Gao, Rong
    Li, Han
    Zheng, Yahui
    Yang, Junling
    IMMUNOTHERAPY, 2024, 16 (07) : 465 - 480
  • [22] Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
    Ouyang, Peng
    Wang, Lijuan
    Wu, Jianlong
    Tian, Yao
    Chen, Caiyun
    Li, Dengsheng
    Yao, Zengxi
    Chen, Ruichang
    Xiang, Guoan
    Gong, Jin
    Bao, Zhen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
    George Lau
    Ming-Lung Yu
    Grace Wong
    Alexander Thompson
    Hepatology International, 2022, 16 : 482 - 483
  • [24] Microfluidic Model for Evaluation of Immune Checkpoint Inhibitors in Human Tumors
    Beckwith, Ashley L.
    Velasquez-Garcia, Luis F.
    Borenstein, Jeffrey T.
    ADVANCED HEALTHCARE MATERIALS, 2019, 8 (11)
  • [25] Exploring the role of immune checkpoint inhibitors in solitary fibrous tumors
    Assi, Tarek
    Moussa, Tania
    Le Cesne, Axel
    IMMUNOTHERAPY, 2025,
  • [26] Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018
    Kabir, Tanvir F.
    Chauhan, Aman
    Anthony, Lowell
    Hildebrandt, Gerhard C.
    OCHSNER JOURNAL, 2018, 18 (04): : 370 - 376
  • [27] Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review
    Yang, Kaili
    Li, Jiarui
    Sun, Zhao
    Zhao, Lin
    Bai, Chunmei
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [28] Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
    Lau, George
    Yu, Ming-Lung
    Wong, Grace
    Thompson, Alexander
    HEPATOLOGY INTERNATIONAL, 2022, 16 (02) : 482 - 483
  • [29] What is the optimal duration of immune checkpoint inhibitors in malignant tumors?
    Yin, Jiaxin
    Song, Yuxiao
    Tang, Jiazhuo
    Zhang, Bicheng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Increasing cure rates of solid tumors by immune checkpoint inhibitors
    Ma, Weijie
    Xue, Ruobing
    Zhu, Zheng
    Farrukh, Hizra
    Song, Wenru
    Li, Tianhong
    Zheng, Lei
    Pan, Chong-xian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
12345